[Expert statements concerning the Seroxat issue].
Asbøll
Edmund
E
D016265:Conflict of Interest; D017277:Drug Approval; D004345:Drug Industry; D006801:Humans; D017374:Paroxetine / Q000009:adverse effects; D017367:Selective Serotonin Reuptake Inhibitors / Q000009:adverse effects
D017374:Paroxetine; D017367:Selective Serotonin Reuptake Inhibitors